Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
Radiation: Amazing Results For Target Cancers
Radiation: Amazing Results For Target Cancers 4

Radiation therapy is a key part of cancer treatment. About 50% of cancer patients get it as part of their treatment. The success of this treatment varies by cancer type.

Knowing which tumors respond best to radiation therapy can greatly improve patient care. By matching treatments to each patient’s needs, we can increase the chance of a cancer cure.

Key Takeaways

  • Cancers like lymphomas and seminomas are highly responsive to radiation therapy.
  • Head and neck cancers, cervical, prostate, and certain lung cancers also show significant response.
  • The genetic makeup of tumors can predict their response to radiation therapy.
  • Tailoring treatment to individual patient needs can improve outcomes.
  • Radiation therapy is a critical component of cancer treatment for many patients.

The Science Behind Radiation in Cancer Treatment

The Science Behind Radiation in Cancer Treatment
Radiation: Amazing Results For Target Cancers 5

Understanding radiation therapy is key to seeing its role in fighting cancer. It damages cancer cells’ DNA, stopping them from growing and killing them. This is why radiation is so effective in treating different cancers.

How Radiation Destroys Cancer Cells

Radiation therapy harms cancer cells by breaking their DNA. This is vital for cell growth and survival. When DNA is too damaged, cells can’t fix themselves and die, stopping tumors from growing.

The success of radiation therapy depends on several things. These include the type of radiation, the dose, and how it’s given. External Beam Radiation Therapy (EBRT) and Brachytherapy are two main types. EBRT sends radiation from outside the body to the tumor. Brachytherapy places a radioactive source close to the tumor.

Type of Radiation Therapy

Description

Advantages

External Beam Radiation Therapy (EBRT)

Radiation is directed from outside the body to the tumor site.

Non-invasive, can be precisely targeted.

Brachytherapy

A radioactive source is placed directly inside or near the tumor.

Delivers high dose directly to tumor, minimizing damage to surrounding tissue.

Historical Development of Radiotherapy

Radiotherapy started in the early 20th century, after Wilhelm Conrad Röntgen found X-rays in 1895. The first X-ray therapy was used in 1896, starting radiation oncology. Technology and our understanding of radiation have made radiotherapy better and safer over time.

Today, radiotherapy includes many techniques like IMRT, SBRT, and proton therapy. These advancements help target tumors better, reducing side effects and improving results for patients.

Types of Radiation Therapy Used in Modern Oncology

Types of Radiation Therapy Used in Modern Oncology
Radiation: Amazing Results For Target Cancers 6

Modern oncology uses many radiation therapy techniques. These are chosen based on the patient’s needs. The type, stage, and location of the tumor also play a role.

External Beam Radiation Therapy (EBRT)

External Beam Radiation Therapy (EBRT) is the most common method. It uses high-energy beams from outside the body to kill cancer cells. This method works well for tumors that are easy to reach and have clear boundaries.

We use advanced technology to make sure the radiation is precise. This helps protect healthy tissues. EBRT can be used alone or with other treatments like surgery or chemotherapy.

Internal Radiation Therapy (Brachytherapy)

Internal Radiation Therapy, also known as Brachytherapy, places radioactive material inside or near the tumor. This method delivers a high dose of radiation directly to the cancer cells. It also reduces damage to healthy tissues nearby.

Brachytherapy is great for treating tumors in places like the prostate, cervix, and breasts. It can be used alone or with EBRT.

Systemic Radiation Therapy

Systemic Radiation Therapy uses radioactive substances in the bloodstream. It targets cancer cells all over the body. This is helpful for cancers that have spread to many places.

This method is good for treating some thyroid cancers and other cancers with widespread cells. We choose patients for this treatment based on their cancer type and stage.

Knowing about the different radiation therapies helps us create better treatment plans. This improves outcomes and quality of life for our patients.

Molecular Determinants of Cancer Radiosensitivity

 

Understanding what makes cancer cells more or less sensitive to radiation is key. This knowledge helps make radiation therapy more effective. The success of radiation therapy depends on the tumor’s molecular makeup.

DNA Repair Pathway Deficiencies

Cancer cells with weak DNA repair systems are more harmed by radiation. DNA repair mechanisms keep our genes stable. Without them, cells become more sensitive to radiation.

Tumors with BRCA1 and BRCA2 gene mutations are more sensitive to radiation. These genes help fix DNA damage.

TGF-Beta Signaling Loss

When TGF-beta signaling is lost, tumors may not respond as well to radiation. TGF-beta helps control cell growth and differentiation. Without it, tumors might resist radiation more.

Studies show TGF-beta affects how tumors react to radiation. Tumors without TGF-beta might need different treatments.

Oxygen Effect and Tumor Hypoxia

Tumors with low oxygen levels are harder to kill with radiation. Oxygen helps fix DNA damage caused by radiation. This makes hypoxic tumors more resistant.

To fight tumor hypoxia, researchers are looking at hypoxia-targeting agents. These could make radiation therapy more effective.

By understanding these factors, we can tailor radiation therapy for each patient. This could lead to better treatment results. Using molecular profiling in radiation oncology could make cancer treatment more personalized and effective.

Lymphomas: Achieving 90%+ Control Rates with Radiation

 

Radiation therapy has shown great success in treating lymphomas, with control rates over 90% in many cases. Lymphomas include both Hodgkin and non-Hodgkin types. These cancers are very responsive to radiation, making it a key treatment option.

Hodgkin Lymphoma Response Patterns

Hodgkin lymphoma responds very well to radiation therapy, leading to high cure rates. The disease’s sensitivity to radiation makes it easier to manage, even in more advanced stages.

  • High cure rates: Radiation therapy achieves significant cure rates in Hodgkin lymphoma patients.
  • Effective disease management: Radiation helps in managing the disease, improving patient outcomes.

Non-Hodgkin Lymphoma Radiation Outcomes

Non-Hodgkin lymphoma, a diverse group of lymphoid malignancies, also benefits from radiation therapy. The response to radiation can vary depending on the specific subtype and stage of the disease.

While some subtypes may respond better to radiation, others may need a combination of treatments. Yet, radiation therapy is a vital part of non-Hodgkin lymphoma treatment.

Involved-Site Radiation Therapy Approaches

Involved-site radiation therapy is a tailored approach that focuses radiation on specific areas where the lymphoma is present. This method minimizes exposure to healthy tissues, reducing side effects.

  1. Targeted treatment: Involved-site radiation therapy targets the lymphoma directly.
  2. Reduced side effects: By minimizing exposure to healthy tissues, this approach reduces the risk of side effects associated with radiation therapy.

As we improve radiation therapy techniques, treating lymphomas is becoming more effective. It’s important to understand how different lymphoma subtypes respond to radiation to improve treatment outcomes.

Seminomas and Testicular Cancer: Exceptional Radiation Response

 

Seminomas show a remarkable response to radiation therapy, making it a key part of treating testicular cancer. This is thanks to the high sensitivity of seminoma cells to radiation. This has led to big improvements in treating this disease.

Why Testicular Cancer Cells Are Highly Radiosensitive

Testicular cancer cells, like seminomas, are very sensitive to radiation. This makes radiation therapy a powerful treatment. Their genetic makeup and ability to die when exposed to radiation are key reasons for this sensitivity.

Treatment Protocols for Different Stages

Treatment plans for seminomas depend on the disease stage. For early-stage seminomas, radiation therapy is often used after removing the testicle. For more advanced stages, it might be combined with chemotherapy. We customize treatment based on the patient’s specific needs, like tumor size and stage.

Long-term Cure Rates Exceeding 90%

One big plus of radiation therapy for seminomas is its high cure rate. Research shows cure rates over 90% are possible, even in advanced cases. This highlights the success of radiation therapy in oncology, giving patients a strong chance of long-term survival.

We keep improving our treatment plans for seminomas. Using advanced techniques like intensity-modulated radiation therapy (IMRT) helps us target tumors better. This reduces harm to healthy tissues around them.

Head and Neck Cancers: The Critical HPV Factor

 

In the field of head and neck cancer, HPV’s role is clear. The human papillomavirus (HPV) affects how well these cancers respond to treatment. We’ve found that HPV-positive cancers do better with radiation and chemotherapy than those without HPV.

HPV-Positive Tumors: 70% Remission with Combined Therapy

Patients with HPV-positive tumors see big improvements with treatment. About 70% of them achieve remission. This success is because HPV-positive cells are more sensitive to radiation. Adding chemotherapy to radiation makes treatment even more effective for them.

“The presence of HPV in head and neck cancers has revolutionized our approach to treatment, allowing for more personalized and effective therapy,” said a leading expert in radiation oncology.

HPV-Negative Cases: 30% Response Rate Challenges

HPV-negative cancers are harder to treat, with only about 30% responding to radiation. This group needs new and stronger treatments to do better. Scientists are working hard to find new ways to help these patients.

Organ Preservation Strategies

Our main goal in treating head and neck cancers is to save the organs. In HPV-positive cases, we often see great results with combined treatments. This means we can keep the organs working, improving patients’ lives. Radiation therapy is key in this effort, delivering precise and effective care.

As we learn more about HPV’s impact on head and neck cancers, we’re getting better at treating them. We’re working to make treatment even better for all patients.

Cervical Cancer: Radiation as Primary Treatment

 

Radiation therapy is key in treating cervical cancer. It uses different methods to hit the cancer hard. It’s often paired with other treatments to boost results.

Combination Approaches with EBRT and Brachytherapy

For cervical cancer, doctors often mix External Beam Radiation Therapy (EBRT) and brachytherapy. EBRT shoots radiation from outside the body. Brachytherapy puts a radioactive source close to the tumor.

Key benefits of combining EBRT and brachytherapy include:

  • Enhanced tumor control through precise targeting
  • Reduced risk of damage to surrounding healthy tissues
  • Improved patient outcomes due to the complementary nature of the two techniques

Benefits of Concurrent Chemoradiation

Concurrent chemoradiation is a big step forward in cervical cancer treatment. It combines chemotherapy and radiation at the same time. This combo boosts survival chances and cuts down on coming back.

The advantages of concurrent chemoradiation are multifaceted:

  1. Increased effectiveness against cancer cells
  2. Potential for reduced treatment duration
  3. Enhanced overall treatment outcomes

Treatment Outcomes by FIGO Stage

The success of radiation therapy in cervical cancer depends on the stage. The International Federation of Gynecology and Obstetrics (FIGO) stages it. Knowing these outcomes helps doctors set realistic hopes and make better plans.

FIGO Stage

Treatment Outcome

I

High cure rates with radiation therapy

II-III

Variable outcomes; often requires combined modality treatment

IV

Palliative care often emphasized; radiation for symptom control

Understanding radiation therapy’s role in cervical cancer treatment is vital. It helps doctors give more tailored and effective care.

Prostate Cancer: Precision Radiation Approaches

Precision radiation therapy has changed how we treat prostate cancer. It brings new hope to patients everywhere. New methods like hypofractionation make treatments more effective and precise.

External Beam vs. Brachytherapy Options

There are different ways to treat prostate cancer with radiation. External beam radiation therapy (EBRT) sends radiation from outside the body. Brachytherapy places radioactive material inside the prostate.

External beam radiation therapy aims at the prostate from outside, protecting nearby tissues. Brachytherapy delivers high doses of radiation right to the tumor.

  • EBRT is often used for localized prostate cancer.
  • Brachytherapy is typically used for early-stage prostate cancer.

Hypofractionation Advances

Hypofractionation gives higher doses of radiation in fewer sessions. It’s promising for treating prostate cancer well and shortening treatment time.

Treatment Approach

Dose per Fraction

Total Fractions

Conventional Fractionation

2 Gy

35-40

Hypofractionation

7-8 Gy

5-6

Long-term Biochemical Control Rates

Research shows precision radiation methods lead to high control rates in prostate cancer. Advanced techniques have greatly improved results.

We keep an eye on patients to see how well these treatments work over time. This ensures the best results for them.

Lung Cancer: Varying Responses to Radiation

Lung cancer treatment with radiation shows different results. This highlights the need for treatments tailored to each patient. The way tumors react to radiation varies, making it key to understand these differences for better treatment plans.

High Initial Radiosensitivity in Small Cell Lung Cancer

Small cell lung cancer (SCLC) quickly responds to radiation. This makes treatment effective in controlling the disease. It’s important to start treatment early to manage SCLC effectively.

The fast response of SCLC to radiation is due to its radiosensitivity. Yet, it’s also vital to consider radiation’s side effects on the body. Knowing how radiation affects the body helps in caring for patients.

Response Patterns in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) has a more varied response to radiation. The differences in tumor biology and genetics among patients lead to different reactions. Some tumors shrink a lot, while others show a smaller response.

We use advanced radiation methods to target tumors better. This helps in controlling tumors more effectively and reduces side effects.

Outcomes with Stereotactic Body Radiation Therapy

Stereotactic body radiation therapy (SBRT) is a highly effective treatment for early-stage NSCLC. It delivers precise, high doses of radiation to the tumor. This results in excellent control of the tumor with minimal side effects.

Studies show SBRT can achieve local control rates over 90% in some cases. It’s a valuable option for patients who can’t have surgery or prefer not to. The table below shows some key outcomes with SBRT in NSCLC.

Tumor Stage

Local Control Rate

Survival Rate

T1

90%

80%

T2

85%

70%

As the table shows, SBRT offers promising results for early-stage NSCLC patients. The precise radiation therapy helps control tumors effectively while preserving lung function.

Contemporary Radiation Protocols for Optimal Outcomes

The field of radiation oncology keeps getting better. New protocols are key to better patient care. Modern radiation therapy aims to hit tumors hard while keeping healthy tissues safe.

Dose Fractionation Optimization

Dose fractionation is a big deal in radiation therapy. It breaks down the total dose into smaller parts. This way, more dose can go to the tumor without harming normal tissues. Optimizing dose fractionation can make treatments more effective and cut down on side effects.

Studies show that different ways of fractionating doses can really change how well treatments work. For example, hypofractionation, which uses bigger doses in fewer fractions, is good for some tumors.

Image-Guided Radiation Therapy

Image-guided radiation therapy (IGRT) uses imaging to guide the radiation. It helps target tumors more accurately, reducing harm to nearby tissues. IGRT is great for tumors near important areas or those that move with breathing.

Adding IGRT to treatment plans has made them more precise and effective. It ensures the radiation hits the tumor right on, protecting healthy tissues.

Adaptive Planning Approaches

Adaptive radiation therapy changes the treatment plan as the tumor changes. This can make treatments more effective and safer.

Adaptive planning needs advanced imaging and planning tools. It lets doctors keep an eye on the tumor and tweak the plan as needed for better results.

Multidisciplinary Cancer Care and Radiation

Cancer treatment needs a detailed plan. This includes radiation therapy, surgery, and systemic therapy. This mix ensures patients get care that fits their needs.

The Tumor Board Approach

A tumor board is a team of doctors who plan treatment together. They look at all parts of a patient’s care, from start to finish.

Our team includes experts in radiation, medicine, surgery, radiology, and pathology. We discuss and decide on the best treatment for each case.

Integrating Radiation with Surgery and Systemic Therapy

Radiation therapy works well with surgery and systemic therapy. Planning and coordination are key to success and fewer side effects.

For instance, radiation can shrink tumors before surgery. After surgery, it kills any cancer cells left. Systemic therapies like chemotherapy can boost radiation’s effect.

Treatment Modality

Purpose

Benefits

Radiation Therapy

Kill cancer cells, shrink tumors

Effective for localized tumors, can be used alone or in combination with other therapies

Surgery

Remove tumors and affected tissues

Can be curative for early-stage cancers, often used in combination with radiation and/or systemic therapy

Systemic Therapy

Target cancer cells throughout the body

Effective for cancers that have spread, can be used in combination with radiation and/or surgery

Patient-Centered Decision Making

At the heart of cancer care is putting the patient first. This means making decisions based on what the patient wants and needs.

We listen to our patients to understand their situation. Then, we create treatment plans that fit their needs. This includes using radiation therapy wisely to avoid side effects.

Our goal is to treat cancer and support the patient’s overall health. By working together, we aim for better outcomes and a better quality of life.

Future Directions in Radiation Oncology

The field of radiation oncology is on the verge of a big change. New technologies and treatment methods are coming. These changes will greatly affect how we fight cancer.

FLASH Radiotherapy

FLASH radiotherapy is a new method that sends radiation at an incredibly fast rate. It looks promising because it might harm healthy tissues less. It could change how we give radiation therapy, making it better for patients.

Studies on FLASH radiotherapy are showing good results. They suggest it could lead to fewer side effects and better lives for patients. As it gets better, it might become a key part of treatment plans.

Artificial Intelligence in Treatment Planning

Artificial intelligence (AI) is making big strides in radiation oncology. AI can look at lots of data to find the best treatment plans. It makes radiation therapy more precise and makes planning easier.

AI can help draw out tumors and areas that might get hurt. This saves time and makes sure treatments are accurate. It also helps doctors by doing some of the work.

Combining Immunotherapy with Radiation

Using radiation with immunotherapy is getting more attention. Radiation can make tumors more visible to the immune system. This mix could lead to better results for many cancers.

More research will show how radiation and immunotherapy can work together. We’ll see new ways to use radiation that fit each patient’s needs. This could lead to even better treatments.

Conclusion

Radiation therapy is a key treatment for many cancers. It offers high cure rates for some and helps manage symptoms for others. Different cancers respond differently to this treatment.

Using radiation therapy with other treatments, like immunotherapy, could lead to even better results. Understanding how cancer responds to radiation will help make treatments more effective.

FAQ

What is radiation therapy and how is it used in cancer treatment?

Radiation therapy is a key part of cancer treatment, used in about half of all cases. It works by damaging the DNA of cancer cells, stopping them from growing.

What types of radiation therapy are used in cancer treatment?

There are several types, including external beam radiation therapy (EBRT), brachytherapy, and systemic radiation therapy. Each type is used for different benefits.

How does the sensitivity of cancer cells to radiation vary?

The sensitivity of cancer cells to radiation depends on several factors. These include DNA repair issues, TGF-beta signaling loss, and tumor hypoxia. Knowing these helps tailor treatment plans.

What cancers are particular responsive to radiation therapy?

Cancers like lymphomas, seminomas, and head and neck, cervix, prostate, and lung cancers respond well to radiation therapy. The effectiveness varies.

How does HPV status affect the treatment of head and neck cancers?

HPV-positive tumors do better with radiation and chemotherapy together. Knowing the HPV status is key for treatment planning.

What is involved-site radiation therapy, and how is it used?

Involved-site radiation therapy targets specific areas of lymphoma. It has high success rates.

What are the benefits of modern radiation therapy protocols?

Modern protocols use advanced techniques like dose optimization and image guidance. These improve treatment results.

How is radiation therapy used in treating cervical cancer?

Radiation therapy, including external beam and brachytherapy, is a main treatment for cervical cancer. Adding chemotherapy improves outcomes.

What are the future directions in radiation oncology?

Future advancements include FLASH radiotherapy and artificial intelligence in planning. Combining radiation with immunotherapy is also being explored.

How does a multidisciplinary approach impact cancer care?

A team approach, involving tumor boards and various treatments, ensures personalized care. It improves treatment outcomes.

What are the side effects of radiation therapy?

Side effects depend on the type of radiation, treatment area, and dose. We aim to reduce side effects while improving treatment results.

Can radiation therapy be used alone or is it always combined with other treatments?

Radiation therapy can be used alone or with surgery and chemotherapy. It depends on the cancer type and stage.

National Center for Biotechnology Information. Evidence-Based Medical Insight. Retrieved from


References

https://pmc.ncbi.nlm.nih.gov/articles/PMC12021777

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology

Prof. MD. Yasemin Altuner Torun

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 42 01